Review of IMS Health undertakings

The Competition Commission has decided against varying or removing undertakings which restrict the way in which IMS Health Incorporated sells its specialized pharmaceutical data services.

From:
Competition and Markets Authority
Published
9 December 2014
Case type:
Reviews of orders and undertakings
Case state:
Closed
Market sector:
Pharmaceuticals
Opened:
1 January 2012
Closed:
26 March 2014

Administrative timetable

  • Published on 18 October 2013 as required by Rule 6 of the Competition Commission Rules of Procedure. Any revisions made to the timetable will be published on this website.
Phase 2 Action
6 August 2013 OFT鈥檚 advice sent to the CC
13 September 2013 Deadline for consultation on OFT鈥檚 advice
September to November 2013 Consideration of OFT鈥檚 advice, responses to consultation and further CC assessment
December 2013 Publish provisional decision on change of circumstances and, as appropriate, a Notice of proposal to release or vary the undertakings
January 2014 Consideration of responses to provisional decision
February 2014 Publish final decision and, as appropriate, a Notice of release or variation of the undertakings

Phase 2

Date of referral: 06/08/2013

Background information

  • 听

News releases

  • (16.08.13)
  • (23.12.13)
  • (26.03.14)

Core documents

Phase 1

IMS Health undertakings review

Affected market: Pharmaceutical Data Services **No. ME/0139/98

Report to CC

Download the

Updates to this page

Published 9 December 2014
Contents